Innoviva (INVA) Total Liabilities (2010 - 2026)
Innoviva's (INVA) quarterly Total Liabilities came in at $200000.0 in Q1 2026, little changed YoY from $200000.0 in Q1 2025, and little changed on a QoQ basis from $200000.0 in Q4 2025.
Analysis
Innoviva (INVA) Total Liabilities (2010 - 2026) Analysis & Trends
Innoviva (INVA) has 17 years of Total Liabilities data on file, last reported at $200000.0 in Q1 2026.
- Quarterly Total Liabilities changed 0.0% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $200000.0, changed 0.0% from the prior year.
- Total Liabilities held at $200000.0 in Q1 2026, from $200000.0 in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $18.7 million in Q2 2022 to a low of $100000.0 in Q4 2023.
- A 5-year average of $2.5 million and a median of $600000.0 in 2024 frame the typical range for Total Liabilities.
- The widest YoY moves for Total Liabilities: up 700.0% in 2022, down 99.98% in 2022.
- Tracing INVA's Total Liabilities over 5 years: stood at $1.6 million in 2022, then plunged by 93.75% to $100000.0 in 2023, then surged by 100.0% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
- The last three Total Liabilities figures came in at $200000.0 (Q1 2026), $200000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4.20 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 1.72 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 4.00 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 10.03 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Innoviva | 1.56 Bn | 984.81 Mn | 90.62 Mn | 100,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 1.80 Mn |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 700,000.00 |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 18.70 Mn |
| Mar 31, 2022 | 12.43 Mn |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 395.43 Mn |